(3R,4S,5S,6R,7R,9R,10Z,11S,12R,13S,14R)-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-10-[2-[heptyl(methyl)amino]ethoxyimino]-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one

C47H89N3O13 — CID 91211420

IUPAC(3R,4S,5S,6R,7R,9R,10Z,11S,12R,13S,14R)-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-10-[2-[heptyl(methyl)amino]ethoxyimino]-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one
SMILESCCCCCCCN(C)CCO/N=C1/[C@H](C)C[C@@](C)(O)[C@H](OC2OC(C)CC(N(C)C)C2O)[C@@H](C)[C@H](OC2CC(C)(OC)C(O)C(C)O2)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@H]1C
InChIInChI=1S/C47H89N3O13/c1-16-18-19-20-21-22-50(14)23-24-58-48-37-28(3)26-45(9,55)42(63-44-38(51)34(49(12)13)25-29(4)59-44)31(6)39(62-36-27-46(10,57-15)41(53)33(8)60-36)32(7)43(54)61-35(17-2)47(11,56)40(52)30(37)5/h28-36,38-42,44,51-53,55-56H,16-27H2,1-15H3/b48-37-/t28-,29?,30+,31+,32-,33?,34?,35-,36?,38?,39+,40-,41?,42-,44?,45-,46?,47-/m1/s1
InChIKeyKMUUKRDTLABGHY-UWADOCNPSA-N
MW904.24 g/mol
LogP4.49
Rot. Bonds17

About (3R,4S,5S,6R,7R,9R,10Z,11S,12R,13S,14R)-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-10-[2-[heptyl(methyl)amino]ethoxyimino]-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one

(3R,4S,5S,6R,7R,9R,10Z,11S,12R,13S,14R)-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-10-[2-[heptyl(methyl)amino]ethoxyimino]-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one (PubChem CID 91211420) has the molecular formula C47H89N3O13 and a molecular weight of 904.24 g/mol. Its IUPAC name is (3R,4S,5S,6R,7R,9R,10Z,11S,12R,13S,14R)-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-10-[2-[heptyl(methyl)amino]ethoxyimino]-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one.

Molecular Properties

Compound Name(3R,4S,5S,6R,7R,9R,10Z,11S,12R,13S,14R)-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-10-[2-[heptyl(methyl)amino]ethoxyimino]-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one
PubChem CID91211420
Molecular FormulaC47H89N3O13
Molecular Weight904.24 g/mol
Exact Mass903.64
IUPAC Name(3R,4S,5S,6R,7R,9R,10Z,11S,12R,13S,14R)-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-10-[2-[heptyl(methyl)amino]ethoxyimino]-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one
SMILESCCCCCCCN(C)CCO/N=C1/[C@H](C)C[C@@](C)(O)[C@H](OC2OC(C)CC(N(C)C)C2O)[C@@H](C)[C@H](OC2CC(C)(OC)C(O)C(C)O2)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@H]1C
InChIInChI=1S/C47H89N3O13/c1-16-18-19-20-21-22-50(14)23-24-58-48-37-28(3)26-45(9,55)42(63-44-38(51)34(49(12)13)25-29(4)59-44)31(6)39(62-36-27-46(10,57-15)41(53)33(8)60-36)32(7)43(54)61-35(17-2)47(11,56)40(52)30(37)5/h28-36,38-42,44,51-53,55-56H,16-27H2,1-15H3/b48-37-/t28-,29?,30+,31+,32-,33?,34?,35-,36?,38?,39+,40-,41?,42-,44?,45-,46?,47-/m1/s1
InChIKeyKMUUKRDTLABGHY-UWADOCNPSA-N
XLogP4.49
TPSA201.67 Ų
H-Bond Donors5
H-Bond Acceptors16
Rotatable Bonds17
Heavy Atoms63
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500904.24
LogP ≤ 54.49
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze (3R,4S,5S,6R,7R,9R,10Z,11S,12R,13S,14R)-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-10-[2-[heptyl(methyl)amino]ethoxyimino]-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3R,4S,5S,6R,7R,9R,10Z,11S,12R,13S,14R)-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-10-[2-[heptyl(methyl)amino]ethoxyimino]-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one?
The IUPAC name of (3R,4S,5S,6R,7R,9R,10Z,11S,12R,13S,14R)-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-10-[2-[heptyl(methyl)amino]ethoxyimino]-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one (CID 91211420) is (3R,4S,5S,6R,7R,9R,10Z,11S,12R,13S,14R)-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-10-[2-[heptyl(methyl)amino]ethoxyimino]-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one.
What is the SMILES notation for (3R,4S,5S,6R,7R,9R,10Z,11S,12R,13S,14R)-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-10-[2-[heptyl(methyl)amino]ethoxyimino]-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one?
The canonical SMILES for (3R,4S,5S,6R,7R,9R,10Z,11S,12R,13S,14R)-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-10-[2-[heptyl(methyl)amino]ethoxyimino]-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one is CCCCCCCN(C)CCO/N=C1/[C@H](C)C[C@@](C)(O)[C@H](OC2OC(C)CC(N(C)C)C2O)[C@@H](C)[C@H](OC2CC(C)(OC)C(O)C(C)O2)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@H]1C.
What is the InChIKey of (3R,4S,5S,6R,7R,9R,10Z,11S,12R,13S,14R)-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-10-[2-[heptyl(methyl)amino]ethoxyimino]-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one?
The InChIKey is KMUUKRDTLABGHY-UWADOCNPSA-N. The full InChI is InChI=1S/C47H89N3O13/c1-16-18-19-20-21-22-50(14)23-24-58-48-37-28(3)26-45(9,55)42(63-44-38(51)34(49(12)13)25-29(4)59-44)31(6)39(62-36-27-46(10,57-15)41(53)33(8)60-36)32(7)43(54)61-35(17-2)47(11,56)40(52)30(37)5/h28-36,38-42,44,51-53,55-56H,16-27H2,1-15H3/b48-37-/t28-,29?,30+,31+,32-,33?,34?,35-,36?,38?,39+,40-,41?,42-,44?,45-,46?,47-/m1/s1.
What are the key properties of (3R,4S,5S,6R,7R,9R,10Z,11S,12R,13S,14R)-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-10-[2-[heptyl(methyl)amino]ethoxyimino]-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one?
(3R,4S,5S,6R,7R,9R,10Z,11S,12R,13S,14R)-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-10-[2-[heptyl(methyl)amino]ethoxyimino]-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one has a molecular weight of 904.24 g/mol, XLogP of 4.49, 17 rotatable bonds, 5 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for (3R,4S,5S,6R,7R,9R,10Z,11S,12R,13S,14R)-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-10-[2-[heptyl(methyl)amino]ethoxyimino]-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one is sourced from PubChem (CID 91211420), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).